Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–1 of 1 stories
Emerging healthcare companies are gearing up for IPOs in 2025, with a focus on digital health innovations. Notably, Aptar Digital Health is partnering with AstraZeneca to develop AI algorithms for chronic kidney disease detection, while Wellgistics Health aims to enhance patient outcomes through integrated digital health solutions.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.